• blackDotwe are accepting new patients
  • blackDotopen 7 days a week
  • blackDotmorning and evening hours
  • blackDotrapid scheduling and insurance verifications
  • blackDotinfusion care experts
  • blackDotwe are accepting new patients
  • blackDotopen 7 days a week
  • blackDotmorning and evening hours
  • blackDotrapid scheduling and insurance verifications
  • blackDotinfusion care experts
Our Therapies

OXLUMO® Infusion Therapy

OXLUMO® (lumasiran) is a small interfering RNA (siRNA) therapeutic indicated for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary and plasma oxalate levels in pediatric and adult patients. This medication targets the hydroxyacid oxidase 1 (HAO1) gene to reduce production of oxalate and is administered as a subcutaneous injection once monthly, with maintenance doses every 3 months.

Meet our Infusion Specialists

  • Jalal Thwainey M.D.

    Jalal Thwainey M.D.

    Medical Director

  • Randy Josey

    Randy Josey

    Director of Partnerships

For Provider

Simplify patient referrals and offer advanced treatment options with our infusion partnership program.

For Patient

There may be a better way to manage your condition – explore infusion therapy.

logo

Cutting-edge infusion therapies and injections for patients with complex chronic conditions and rare diseases.

instagramfacebooklinkedinTwitter

© 2025 violet health®: Infusion Care. All rights reserved.